1. Home
  2. BREA vs EVAX Comparison

BREA vs EVAX Comparison

Compare BREA & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BREA
  • EVAX
  • Stock Information
  • Founded
  • BREA 2022
  • EVAX 2008
  • Country
  • BREA Ireland
  • EVAX Denmark
  • Employees
  • BREA N/A
  • EVAX N/A
  • Industry
  • BREA Services-Misc. Amusement & Recreation
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BREA Consumer Discretionary
  • EVAX Health Care
  • Exchange
  • BREA Nasdaq
  • EVAX Nasdaq
  • Market Cap
  • BREA 8.7M
  • EVAX 8.7M
  • IPO Year
  • BREA 2023
  • EVAX 2021
  • Fundamental
  • Price
  • BREA $0.63
  • EVAX $2.49
  • Analyst Decision
  • BREA
  • EVAX Strong Buy
  • Analyst Count
  • BREA 0
  • EVAX 3
  • Target Price
  • BREA N/A
  • EVAX $33.33
  • AVG Volume (30 Days)
  • BREA 39.6K
  • EVAX 6.9M
  • Earning Date
  • BREA 01-03-2025
  • EVAX 03-26-2025
  • Dividend Yield
  • BREA N/A
  • EVAX N/A
  • EPS Growth
  • BREA N/A
  • EVAX N/A
  • EPS
  • BREA N/A
  • EVAX N/A
  • Revenue
  • BREA $2,872,101.00
  • EVAX $3,295,000.00
  • Revenue This Year
  • BREA N/A
  • EVAX $9,039.73
  • Revenue Next Year
  • BREA N/A
  • EVAX $1.47
  • P/E Ratio
  • BREA N/A
  • EVAX N/A
  • Revenue Growth
  • BREA 2338.69
  • EVAX N/A
  • 52 Week Low
  • BREA $0.50
  • EVAX $2.22
  • 52 Week High
  • BREA $2.44
  • EVAX $22.50
  • Technical
  • Relative Strength Index (RSI)
  • BREA 38.35
  • EVAX 39.85
  • Support Level
  • BREA $0.60
  • EVAX $2.30
  • Resistance Level
  • BREA $0.67
  • EVAX $2.80
  • Average True Range (ATR)
  • BREA 0.04
  • EVAX 0.51
  • MACD
  • BREA -0.01
  • EVAX 0.03
  • Stochastic Oscillator
  • BREA 13.91
  • EVAX 6.97

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

Share on Social Networks: